Literature DB >> 20532959

Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis.

Indranil Banerjee1.   

Abstract

Genetic variants of paraoxonase 1 (PON1) were implicated in stroke susceptibility in several case-control association studies. However, the studies have reported apparently conflicting results, rendering precise assessment of the disease risk associated with the variants difficult. A meta-analysis was therefore conducted by including the studies that examined the association between two common polymorphisms (L55M and Q192R) in the coding region of PON1 gene and the risk of stroke. Altogether 10 studies on L55M polymorphism and 11 studies on Q192R polymorphism were included in this meta-analysis. The results showed, although there was no significant association of the 55L allele with stroke [random effects OR = 1.09, 95% CI (0.93, 1.27), P = 0.29], the 192R allele conferred significant risk of stroke in the overall study population [random effects OR = 1.25, 95% CI (1.07, 1.46), P = 0.006]. Same pattern of results as both the allele contrasts was obtained for the homozygote contrasts and the dominant, recessive and additive models. Subgroup analyses for stroke type, age of patients and ethnicity revealed no association of the 55L allele with stroke, whereas the association of the 192R allele persisted significantly in the groups comprising ischemic stroke patients, stroke patients with mean age >60 years and Caucasian subjects. But no significant association of this allele with stroke susceptibility was detected in the East Asian population. Therefore, the results of this meta-analysis indicate, the Q192R polymorphism could be an important risk factor for stroke, especially in the Caucasian population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532959     DOI: 10.1007/s10654-010-9470-4

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  49 in total

Review 1.  Genetic associations in large versus small studies: an empirical assessment.

Authors:  John P A Ioannidis; Thomas A Trikalinos; Evangelia E Ntzani; Despina G Contopoulos-Ioannidis
Journal:  Lancet       Date:  2003-02-15       Impact factor: 79.321

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.

Authors:  S M Herrmann; H Blanc; O Poirier; D Arveiler; G Luc; A Evans; P Marques-Vidal; J M Bard; F Cambien
Journal:  Atherosclerosis       Date:  1996-10-25       Impact factor: 5.162

4.  Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

Authors:  D K Sanghera; N Saha; C E Aston; M I Kamboh
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-06       Impact factor: 8.311

5.  A general estimator for the variance of the Mantel-Haenszel odds ratio.

Authors:  J Robins; S Greenland; N E Breslow
Journal:  Am J Epidemiol       Date:  1986-11       Impact factor: 4.897

Review 6.  Genetic polymorphism in paraoxonase 1 (PON1): Population distribution of PON1 activity.

Authors:  Gary Ginsberg; Patricia Neafsey; Dale Hattis; Kathryn Z Guyton; Douglas O Johns; Babasaheb Sonawane
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2009       Impact factor: 6.393

7.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

8.  Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

Authors:  M I Mackness; S Arrol; C Abbott; P N Durrington
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

9.  Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk.

Authors:  Larry Baum; Ho Keung Ng; Kam Sang Woo; Brian Tomlinson; Timothy Hudson Rainer; Xiangyan Chen; Wing Sze Cheung; Daniel Kam Yin Chan; G Neil Thomas; Cindy See Wai Tong; Ka Sing Wong
Journal:  Clin Biochem       Date:  2006-02-09       Impact factor: 3.281

Review 10.  Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches.

Authors:  Steve E Humphries; Laleh Morgan
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

View more
  19 in total

1.  Meta-analysis of association between cytokine gene polymorphisms and lung cancer risk.

Authors:  Wen-Jia Peng; Qian He; Jin-Xia Yang; Bing-Xiang Wang; Man-Man Lu; Song Wang; Jing Wang
Journal:  Mol Biol Rep       Date:  2011-12-09       Impact factor: 2.316

2.  Paraoxonase 1 (PON1) gene variants are not associated with clopidogrel response.

Authors:  J P Lewis; A S Fisch; K Ryan; J R O'Connell; Q Gibson; B D Mitchell; H Shen; K Tanner; R B Horenstein; R Pakzy; U S Tantry; K P Bliden; P A Gurbel; A R Shuldiner
Journal:  Clin Pharmacol Ther       Date:  2011-08-31       Impact factor: 6.875

3.  Association between PON1 L55M polymorphism and ischemic stroke: a systematic review and meta-analysis.

Authors:  Peng Shao; Da-Jun Qu; Rui-Ying Song; Ming-Lu Chen; Li-Hua Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  R-carrying genotypes of serum paraoxonase (PON1) 192 polymorphism and higher activity ratio are related to susceptibility against ischemic stroke.

Authors:  Abdolkarim Mahrooz; Ghorban Gohari; Mohammad-Bagher Hashemi; Mehryar Zargari; Hadis Musavi; Mahmoud Abedini; Ahad Alizadeh
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

5.  A new PCR method: one primer amplification of PCR-CTPP products.

Authors:  Guang Yin; Yoko Mitsuda; Takayuki Ezaki; Nobuyuki Hamajima
Journal:  Mol Biotechnol       Date:  2012-10       Impact factor: 2.695

Review 6.  The effect of TGF-β1 polymorphism on systemic sclerosis: a systematic review and pooled analysis of available literature.

Authors:  Ya-nan Wan; Yu-jie Wang; Jun-wei Yan; Xiang-pei Li; Jin-hui Tao; Bing-xiang Wang; Wen-jia Peng; Jing Wang
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

7.  Cytochrome P450 2A6 deletion polymorphism and risk of lung cancer: a meta-analysis.

Authors:  Zheng-Bing Liu; Jun Shu; Li-Ping Wang; Cheng Jin; Zhi-Xia Lou
Journal:  Mol Biol Rep       Date:  2013-06-04       Impact factor: 2.316

8.  TLR7 rs2897827 Polymorphism Affects TLR7 Gene mRNA Expression and Serum Apolipoprotein A1 Level of Ischemic Stroke Patients in a Chinese Han Population.

Authors:  Lian Gu; Jinying Zhou; Jinjing Tan; Li Su; Qiugui Wei; Haiyun Jiang; Baoyun Liang; Qianli Tang
Journal:  J Mol Neurosci       Date:  2016-07-18       Impact factor: 3.444

Review 9.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

10.  Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases.

Authors:  Dmitry Litvinov; Halleh Mahini; Mahdi Garelnabi
Journal:  N Am J Med Sci       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.